Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07867236
NA

Osteogenic Potential of Topical Metformin Gel on Cystic Jaw Defects

Sponsor: Fayoum University

View on ClinicalTrials.gov

Summary

Evaluate the osteogenic effect of locally applied 1% metformin gel on bone volume formation after jaw cystic defects enucleation

Official title: Assessment of Osteogenic Potential of Topical Metformin Gel on Bone Regeneration in Cystic Jaw Defects: Randomized Controlled Clinical Trial

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2026-10-30

Completion Date

2027-10-30

Last Updated

2026-10-14

Healthy Volunteers

Yes

Interventions

DRUG

For the Experimental Arm: 1% Metformin Gel

1\. For 1% Metformin Gel (Experimental Arm): Intervention Description: Pure metformin hydrochloride powder is dissolved into a biocompatible, in-situ gelling base at a concentration of 10 mg/ml to prepare a high-viscosity 1% metformin gel. Following surgical enucleation and thorough irrigation of the odontogenic cystic cavity, the gel is applied directly into the residual bony defect to act as a bioactive tissue-engineering matrix.

DRUG

For the Comparator / Control Arm: Placebo Gel

For Placebo Gel (Comparator Arm): Intervention Description: A visually and physically identical methylcellulose-based placebo gel. Following surgical enucleation and thorough irrigation of the odontogenic cystic cavity, the placebo gel is applied directly into the residual bony defect in an identical manner to maintain double-blinding

Locations (1)

Fayoum University

Al Fayyum, Faiyum Governorate, Egypt